XML 60 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Collaboration Agreements And Business Development Activities- Royalty Revenues under the Collaboration Agreement with Genentech (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 01, 2022
Jul. 02, 2021
Jul. 01, 2022
Jul. 02, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Royalty revenues on ex-U.S. sales $ 419,427 $ 385,177 $ 775,407 $ 655,407
Collaborative Arrangement with Genentech | Cotellic        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Profits on U.S. commercialization 1,682 2,160 3,821 3,954
Royalty revenues on ex-U.S. sales $ 889 $ 782 $ 2,517 $ 1,733